Status of COVID-19 Medicines and Active Pharmaceutical Ingredients (APIs) updated
M
Revised Invitation for Expression of Interest (EOI) for medicines against HIV infection and related diseases published
M
The 20th Invitation for Expression of Interest (EOI) for medicines against HIV infection and related diseases, is published with the following changes:
A) The followin
Hetero’s ritonavir prequalified
M
WHO Prequalification Unit (PQT) added the below new product to its prequalified list:
Two PQT Medicines trainings for regulators in 2022
M
Two PQT Medicines (virtual) trainings for regulators will take palce during June 2022.